
Sign up to save your podcasts
Or


2023 ended with an exciting biotech breakthrough for sickle cell patients. A gene-editing therapy using the revolutionary CRISPR technology provides new hope and options for the nearly 100,000 Americans with sickle cell disease. In this episode, we talk with the company behind one of the life-changing therapies, CASGEVY, and speak with two advocates for sickle cell patients.
By Biotechnology Innovation Organization4.9
8383 ratings
2023 ended with an exciting biotech breakthrough for sickle cell patients. A gene-editing therapy using the revolutionary CRISPR technology provides new hope and options for the nearly 100,000 Americans with sickle cell disease. In this episode, we talk with the company behind one of the life-changing therapies, CASGEVY, and speak with two advocates for sickle cell patients.

2,053 Listeners

756 Listeners

761 Listeners

600 Listeners

818 Listeners

311 Listeners

113,121 Listeners

506 Listeners

397 Listeners

125 Listeners

337 Listeners

116 Listeners

152 Listeners

279 Listeners

263 Listeners